Replimune (REPL) Net Cash Flow (2017 - 2026)

Replimune (REPL) has 10 years of Net Cash Flow data on file, last reported at $86.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 239.73% year-over-year to $86.0 million; the trailing twelve-month figure through Mar 2026 stood at $96.8 million (up 166.28% YoY), and the FY2026 full-year result was $96.8 million, up 166.28% from the prior year.
• Net Cash Flow rose to $86.0 million in Q1 2026, from $19.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $117.7 million in Q4 2022 to a low of -$61.6 million in Q1 2025.
• A 5-year average of $4.4 million and a median of -$12.1 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 523.56% in 2022 and slumped 1015.61% in 2023, its largest moves.
• Tracing REPL's Net Cash Flow over 5 years: stood at $117.7 million in 2022, then sank by 81.57% to $21.7 million in 2023, then surged by 171.38% to $58.9 million in 2024, then plunged by 66.69% to $19.6 million in 2025, then soared by 338.53% to $86.0 million in 2026.
• Business Quant data shows REPL's Net Cash Flow at $86.0 million in Q1 2026, $19.6 million in Q4 2025, and $3.3 million in Q3 2025.